Johnson & Johnson Archives - Page 10 of 33

Johnson & Johnson launches Bay Area science and technology campus

Johnson & Johnson (NYSE:JNJ) has opened an almost 200,000 ft2 science and technology campus in the San Francisco Bay Area. The new facility more than doubles the presence of the company in the Bay Area, which has been a hub for life sciences innovation for decades. Up to 400 employees will work at the facility.

“This campus is our downpayment in our ability to innovate for the future,” said Johnson & Johnson CEO Joaquin Duato at an opening ceremony for the facility in Brisbane, California.

Get the full story from our sister site, Drug Discovery & Development.

Report: J&J Vision spending €100 million to expand Irish facility

Johnson & Johnson Vision reportedly plans to invest €100m in the expansion of its Plassey, Limerick, Ireland facility.

The Irish Examiner reported last week that the company plans to expand and create 80 new jobs at the location. In March, the company announced a €35 million investment in the same facility. That cash infusion aimed to create more than 200 jobs over the next three years.

According to the report, Johnson & Johnson Vision believes the investment allows for the expansion of its manufacturing capability. It plans to introduce fully automated flexible manufacturing lines with the added funds at the contact lens manufacturing site.

The Irish Examiner said the extension to the J&J Vision site already began. Production is slated to begin in 2024 and the company is recruiting for new roles. Positions include process and production technicians, as well as manufacturing engineers and lab technicians.

J&J Vis…

Medtech relief efforts begin after Hurricane Fiona hits Puerto Rico

Hurricane Fiona is still dropping rain on Puerto Rico as it moves toward the Dominican Republic, as seen in this Sept. 19, 2022 satellite imagery. [Image courtesy of the National Oceanic and Atmospheric Administration]

Power crews are restoring electricity in Puerto Rico after Hurricane Fiona struck with heavy rains and winds five years after Hurricane Maria made landfall.

Many large medtech companies have manufacturing operations in the U.S. island territory.

Medtronic (NYSE: MDT) has not received any reports of significant damage to its five facilities in Puerto Rico and planned to restart operations today if employees are safe and can report to work, the company told Medical Design & Outsourcing. The company also has a manufacturing facility in the Dominican Republic.

“Given the path of Hurricane Fiona, our teams have been monitoring and are continuing to monitor both Puerto Rico and …

J&J announces $5B share repurchase

Johnson & Johnson (NYSE: JNJ) announced today that its board has authorized a $5 billion repurchase of its common stock.

“The last few years have demonstrated the resilience of Johnson & Johnson. With continued confidence in our business and pipeline, the board of directors and management team believe that company shares are an attractive investment opportunity,” J&J CEO Joaquin Duato said in a news release. “With our strong cash flow and lowest level of net debt in five years, we have the ability to invest in innovation, grow our dividend, execute strategic acquisitions, and take this action to deliver shareholder returns and drive long-term growth.”

Criticism over its ‘Texas two-step’

The $5 billion stock repurchase comes at the same time that J&J is facing scrutiny over a complex maneuver nicknamed the “Texas two-step.” Critics allege that J&J is seeking to shield itself from billions of dollars worth of lawsuit pa…

J&J settles big Australian pelvic mesh case

[Image from Unsplash]Johnson & Johnson (NYSE: JNJ) has settled an Australian pelvic mesh class action suit for AU$300 million (roughly U.S. $205 million), according to media reports.

Shine Lawyers, which handled the suit, confirmed the settlement. It still requires court approval. More than 11,000 claimants in Australia had sought relief, according to Reuters.

In a statement shared with MassDevice by a spokesperson, Johnson & Johnson and its Ethicon subsidiary said that pending Federal Court approval, they are pleased to reach a settlement that “provides certainty and a path forward for eligible Australian patients.”

The statement added: “Ethicon empathizes with all women who experience medical complications related to pelvic organ prolapse or stress urinary incontinence. These are extremely complex medical conditions, and Ethicon has strived to support the availability of treatment options for women with these conditions.” Read more

Johnson & Johnson Vision launches new contact lenses

Johnson & Johnson Vision announced today that it launched its new Acuvue Oasys Max 1-day contact lenses and multifocal lenses for presbyopia.

The lenses feature Johnson & Johnson’s TearStable technology for tear-film stability and locking in moisture. They also offer the OptiBlue light filter for filtering blue-violet to reduce light scatter for visual clarity.

Johnson & Johnson said in a news release that the Acuvue Oasys Max 1-day lenses block 99.9% of UVA rays and 100% of UVB rays.

“Life has changed, post-pandemic. With more time spent on digital devices, we designed these contact lenses by listening to patients and eye care professionals’ feedback to address lifestyle requirements and help prevent dry and tired eyes from becoming normalized,” said John Buch, senior principal research optometrist, Johnson & Johnson Vision. “Our new Acuvue Oasys Max 1-day contact lenses help reduce discomfort by providing v…

What are the largest medical device companies?

Medtronic, Johnson & Johnson MedTech and Siemens Healthineers top the Big 100 list of largest medical device companies by revenue.

The 2022 edition of MassDevice and Medical Design & Outsourcing‘s Big 100 report also holds surprises. Big conglomerates are spinning out medtech businesses as stand-alone companies, and that means changes to the list of 100 largest medical device companies.

Colfax, for example, engaged in business moves that turned DJO’s parent into Enovis, a large, stand-alone orthopedic device company that is No. 56 in 2022’s Big 100. ZimVie, formerly Zimmer Biomet’s spine and dental business, is 69th. And after decades under larger corporate umbrellas, Cordis debuts at No. 76 on the list.

We collected thousands of data points to size up the industry’s publicly traded companies and privately held firms. The Big 100 includes annual revenue, R&D spending, employee counts, key leaders, headquarters locatio…

Join us at DeviceTalks West, the World’s Fair of Medtech

Intuitive Surgical CEO Gary Guthart will participate in a keynote interview at DeviceTalks West 2022. [Photo courtesy of Intuitive Surgical]

October’s DeviceTalks West conference is focused on the future.

The best-seller “Devil in the White City” may have darkened the perception of world’s fairs, but these international convocations have long presented visitors with an optimistic and hopeful view of the future, thanks in no small part to new technology. (The next one is scheduled for 2025 in Osaka, Japan, by the way.)

I like to think we’ll be following similar guidelines at the upcoming DeviceTalks West conference, which will be held on Oct. 19-20 at the Santa Clara Convention Center.

This event will bring together executives from Abbott, Boston Scientific, Edwards Lifesciences, Intuitive, Johnson & Johnson, Medtronic, Outset Medical, Penumbra, Shockwave, Zimmer Biomet and many …

16 surgical robotics companies you need to know

Intuitive remains the dominant surgical robotics company, but corporations ranging from Medtronic to Vicarious Surgical look to compete. The Da Vinci Xi robotic surgery system. Intuitive continues to dominate the space. [Image courtesy of Intuitive]Robotic-assisted surgery remains one of the hottest spaces in medtech. Intuitive, which pioneered the field in the 1990s and early 2000s, continues to innovate. At the same time, a host of other companies are looking to compete.

Companies making headlines in the robotic surgery space over the past year include:

Company Robotic system(s) Intuitive Surgical Da Vinci Xi, Da Vinci X, Da Vinci SP, Ion Medtronic Hugo Johnson & Johnson Monarch, Velys, Ottava Stryker Mako Siemens Healthineers’ Corindus CorPath GRX Vicarious Surgical Beta 2 Titan Medical Enos Asensus Surgical Senhance Moon Surgical Maestro Momentus Surgical Anovo Virtual Incision MIRA Stereotaxis Genesis RMN, Vdrive, Niobe Monteris …

J&J’s Acclarent wins FDA clearance for navigated shaver blade for ENT procedures

Johnson & Johnson MedTech’s Acclarent business announced FDA 510(k) clearance for its TruDi shaver blade and its advanced navigation features.

In a news release posted yesterday, Acclarent described TruDI as a single-use electromagnetically navigated blade. It’s used with the company’s Bien-Air S120 shaver for the incision and removal of soft and hard tissue or bone in ENT, maxillofacial surgery, head and neck, and ENT skull base surgery.

The TruDi shaver blade is navigable. It has distal tip sensor integration, enabling the display of the blade’s position and opening on the TruDi navigation system.

“When performing endoscopic sinus procedures, every millimeter counts, so a navigable shaver blade connected to a sophisticated mapping system that provides real-time visualization of the blade location helps me know where I am, where my trainees are, and where we are going during surgery,” said Dr. C.S. Ebert Jr. professor at the Depart…

How an Embotrap stent retriever thrombectomy treats ischemic strokes

Michael Gilvarry is the GM of Cerenovus in Galway, Ireland. [Photo courtesy of Johnson & Johnson MedTech]Gilvarry is the GM of Cerenovus in Galway, Ireland. [Photo courtesy of Johnson & Johnson Medtech]

To catch a clot, you must first understand a clot, and Michael Gilvarry has spent years doing just that.

Gilvarry is the GM of Cerenovus in Galway, Ireland. He founded the Johnson & Johnson Medtech unit’s stroke science research arm and leads the acute ischemic stroke R&D portfolio.

That research led to the development and design of the Embotrap stent retriever device for thrombectomies, which helps stroke patients by removing the clots blocking the flow of blood to their brains.

“How the device design is informed by stroke science is something that we feel is really unique about the device,” he said in an interview. “All of that work we’ve done has le…

The 10 largest orthopedic device companies in the world

Stryker, Johnson & Johnson’s DePuy Synthes and Zimmer Biomet top the list of largest orthopedic device companies. [Adobe Stock image]With elective procedure numbers rebounded after the darkest days of the COVID-19 pandemic, most of the world’s largest orthopedic device companies saw their revenues increase by double-digit percentages during their most recent fiscal years.

Here are the world’s 10 largest orthopedic device companies, ranked by ortho business revenue pulled from their most recent annual reports:

Largest orthopedic device companies Annual revenue (% change) Headquarters 1 Stryker $17.1 billion (+19.2%) Kalamazoo, Michigan 2 Johnson & Johnson – DePuy Synthes $8.6 billion (+10.6%) Locations: Raynham, Massachusetts.; West Chester, Pennsylvania; Warsaw, Indiana; Palm Beach Gardens, Florida 3 Zimmer Biomet (minus ZimVie spinoff) $6.8 billion (+11.6%) Warsaw, Indiana 4 Medtronic – Cranial & Spinal Technologies $4.5 billion (+3.9%) Locat…